Drugs that contain Cefiderocol Sulfate Tosylate
1. Drug name - FETROJA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US9238657 | SHIONOGI INC | Cephalosporin having catechol group |
Nov, 2031
(9 years from now) | |
| US10004750 | SHIONOGI INC | Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof |
Sep, 2035
(12 years from now) | |
| CN102203100B | SHIONOGI INC | Cephalosporin Having A Catechol Group |
Oct, 2029
(7 years from now) | |
| CN102203100A | SHIONOGI INC | Cephalosporin Having Catechol Group |
Oct, 2029
(7 years from now) | |
| CN106795176A | SHIONOGI INC | Salt Of Cephalosporin Derivatives, Its Crystalline Solid And Its Manufacturing Method |
Sep, 2035
(12 years from now) | |
| CN106795176B | SHIONOGI INC | Salts Of Cephalosporin Derivatives, Crystalline Solid Thereof, And Process For Producing The Same |
Sep, 2035
(12 years from now) | |
| IN293935B | SHIONOGI INC | Cephalosporin Having Catechol Group |
Oct, 2029
(7 years from now) | |
| IN201101800P4 | SHIONOGI INC | Cephalosporin Having Catechol Group |
Oct, 2029
(7 years from now) | |
| EP2341053A1 | SHIONOGI INC | Cephalosporin Having Catechol Group |
Oct, 2029
(7 years from now) | |
| EP2341053B1 | SHIONOGI INC | Cephalosporin Having Catechol Group |
Oct, 2029
(7 years from now) | |
| EP2341053A4 | SHIONOGI INC | Cephalosporin Having Catechol Group |
Oct, 2029
(7 years from now) | |
| EP2960244B1 | SHIONOGI INC | Cephalosporin Having Catechol Group |
Oct, 2029
(7 years from now) | |
| EP2960244A1 | SHIONOGI INC | Cephalosporin Having Catechol Group |
Oct, 2029
(7 years from now) | |
| EP3190115A4 | SHIONOGI INC | Salt Of Cephalosporin Derivative, Crystalline Solid Form Of Same And Method For Producing Same |
Sep, 2035
(12 years from now) | |
| EP3190115A1 | SHIONOGI INC | Salt Of Cephalosporin Derivative, Crystalline Solid Form Of Same And Method For Producing Same |
Sep, 2035
(12 years from now) | |
| EP3190115B1 | SHIONOGI INC | Salt Of Cephalosporin Derivative, Crystalline Solid Form Of Same And Method For Producing Same |
Sep, 2035
(12 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9949982 | SHIONOGI INC | Preparation containing cephalosporin having a catechol moiety |
Sep, 2035
(12 years from now) | |
Treatment: NA
Dosage: POWDER;INTRAVENOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 1GM BASE/VIAL | POWDER;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.